NCT01755975 · OUTCOME
Complete Response Rate/CRR
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- COUNT_OF_PARTICIPANTS
- Unit
- Participants
- Interval / dispersion
- Not reported
- Time frame
- 1 year
What was measured
CRR is defined as Complete Response Rate. Per Response Evaluation Criteria In Solid Tumors Criteria (RECIST v1.0) for target lesions and assessed by MRI: Complete Response (CR), Disappearance of all target lesions; Partial Response (PR), \>=30% decrease in the sum of the longest diameter of target lesions; Overall Response (OR) = CR + PR.
Analysis population: No participants treated on Dose Level -1
Groups in this outcome
Dose Level -1
Romidepsin 8 mg/m\^2/Lenalidomide 10 mg
Dose Level 1
Romidepsin 8 mg/m\^2/Lenalidomide 15 mg
Dose Level 2
Romidepsin 8 mg/m\^2/Lenalidomide 25 mg
Dose Level 3
Romidepsin 10 mg/m\^2/Lenalidomide 25 mg
Dose Level 4
Romidepsin 14 mg/m\^2/Lenalidomide 25 mg
| Group | Source count |
|---|---|
| Dose Level -1 | 0 |
| Dose Level 1 | 3 |
| Dose Level 2 | 7 |
| Dose Level 3 | 3 |
| Dose Level 4 | 36 |
Reported measurements
Source class 1
Complete Response
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Dose Level 1 | 1 | Not reported | Not reported | Not reported | Not reported |
| Dose Level 2 | 1 | Not reported | Not reported | Not reported | Not reported |
| Dose Level 3 | 0 | Not reported | Not reported | Not reported | Not reported |
| Dose Level 4 | 6 | Not reported | Not reported | Not reported | Not reported |
No Complete Response
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Dose Level 1 | 2 | Not reported | Not reported | Not reported | Not reported |
| Dose Level 2 | 6 | Not reported | Not reported | Not reported | Not reported |
| Dose Level 3 | 3 | Not reported | Not reported | Not reported | Not reported |
| Dose Level 4 | 30 | Not reported | Not reported | Not reported | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG001
- value
- 1
- group Id
- OG002
- value
- 1
- group Id
- OG003
- value
- 0
- group Id
- OG004
- value
- 6
- title
- Complete Response
- measurements
- group Id
- OG001
- value
- 2
- group Id
- OG002
- value
- 6
- group Id
- OG003
- value
- 3
- group Id
- OG004
- value
- 30
- title
- No Complete Response
- denoms
- counts
- group Id
- OG000
- value
- 0
- group Id
- OG001
- value
- 3
- group Id
- OG002
- value
- 7
- group Id
- OG003
- value
- 3
- group Id
- OG004
- value
- 36
- units
- Participants
- description
- CRR is defined as Complete Response Rate. Per Response Evaluation Criteria In Solid Tumors Criteria (RECIST v1.0) for target lesions and assessed by MRI: Complete Response (CR), Disappearance of all target lesions; Partial Response (PR), \>=30% decrease in the sum of the longest diameter of target lesions; Overall Response (OR) = CR + PR.
- groups
- description
- Romidepsin 8 mg/m\^2/Lenalidomide 10 mg
- id
- OG000
- title
- Dose Level -1
- description
- Romidepsin 8 mg/m\^2/Lenalidomide 15 mg
- id
- OG001
- title
- Dose Level 1
- description
- Romidepsin 8 mg/m\^2/Lenalidomide 25 mg
- id
- OG002
- title
- Dose Level 2
- description
- Romidepsin 10 mg/m\^2/Lenalidomide 25 mg
- id
- OG003
- title
- Dose Level 3
- description
- Romidepsin 14 mg/m\^2/Lenalidomide 25 mg
- id
- OG004
- title
- Dose Level 4
- param Type
- COUNT_OF_PARTICIPANTS
- population Description
- No participants treated on Dose Level -1
- reporting Status
- POSTED
- time Frame
- 1 year
- title
- Complete Response Rate/CRR
- type
- SECONDARY
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle